Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Capelli

Showing results (141-150 of 163) with videos related to

Pageof 17
Sort By:
La Chirurgia Degli Organi Di Movimento|April 1, 1994
The results of a multicenter Italian study on the use of the Gamma nail for the treatment of pertrochanteric and subtrochanteric fractures: a review of 1181 casesS Boriani, F De Iure, G Bettelli, et al.
Gynecologic Oncology|April 1, 1993
Type II estrogen-binding sites in human ovarian cancer: correlation with estrogen, progesterone, and epidermal growth factor receptorG Ferrandina, G Scambia, P Benedetti Panici, et al.
International Journal of Cancer|December 15, 1990
Type-II estrogen binding sites in a lymphoblastoid cell line and growth-inhibitory effect of estrogen, anti-estrogen and bioflavonoidsG Scambia, F O Ranelletti, P Benedetti Panici, et al.
Gynecologic Oncology|July 1, 1996
Lymphatic spread of cervical cancer: an anatomical and pathological study based on 225 radical hysterectomies with systematic pelvic and aortic lymphadenectomyP Benedetti-Panici, F Maneschi, G Scambia, et al.
The Journal of Investigative Dermatology|August 1, 1995
Tamoxifen and quercetin interact with type II estrogen binding sites and inhibit the growth of human melanoma cellsM Piantelli, N Maggiano, R Ricci, et al.
Cancer|January 1, 1993
Type II estrogen binding sites and antiproliferative activity of quercetin in human meningiomasM Piantelli, A Rinelli, E Macrì, et al.
Gynecologic Oncology|April 1, 1996
Locally advanced cervical adenocarcinoma: is there a place for chemo-surgical treatment?P Benedetti-Panici, S Greggi, G Scambia, et al.
Journal of Neurosurgical Sciences|July 1, 1990
Type II estrogen binding sites (EBS) in intracranial tumorsA Capelli, M Piantelli, A Rinelli, et al.
International Journal of Cancer|February 1, 2000
Quercetin inhibits p21-RAS expression in human colon cancer cell lines and in primary colorectal tumorsF O Ranelletti, N Maggiano, F G Serra, et al.
Gynecologic Oncology|April 1, 1992
Inhibitory effect of quercetin on primary ovarian and endometrial cancers and synergistic activity with cis-diamminedichloroplatinum (II)G Scambia, F O Ranelletti, P Benedetti Panici, et al.
Pageof 17

Showing results (141-150 of 163) with videos related to

Sort By:
Pageof 17
La Chirurgia Degli Organi Di Movimento|April 1, 1994
The results of a multicenter Italian study on the use of the Gamma nail for the treatment of pertrochanteric and subtrochanteric fractures: a review of 1181 casesS Boriani, F De Iure, G Bettelli, et al.
Gynecologic Oncology|April 1, 1993
Type II estrogen-binding sites in human ovarian cancer: correlation with estrogen, progesterone, and epidermal growth factor receptorG Ferrandina, G Scambia, P Benedetti Panici, et al.
International Journal of Cancer|December 15, 1990
Type-II estrogen binding sites in a lymphoblastoid cell line and growth-inhibitory effect of estrogen, anti-estrogen and bioflavonoidsG Scambia, F O Ranelletti, P Benedetti Panici, et al.
Gynecologic Oncology|July 1, 1996
Lymphatic spread of cervical cancer: an anatomical and pathological study based on 225 radical hysterectomies with systematic pelvic and aortic lymphadenectomyP Benedetti-Panici, F Maneschi, G Scambia, et al.
The Journal of Investigative Dermatology|August 1, 1995
Tamoxifen and quercetin interact with type II estrogen binding sites and inhibit the growth of human melanoma cellsM Piantelli, N Maggiano, R Ricci, et al.
Cancer|January 1, 1993
Type II estrogen binding sites and antiproliferative activity of quercetin in human meningiomasM Piantelli, A Rinelli, E Macrì, et al.
Gynecologic Oncology|April 1, 1996
Locally advanced cervical adenocarcinoma: is there a place for chemo-surgical treatment?P Benedetti-Panici, S Greggi, G Scambia, et al.
Journal of Neurosurgical Sciences|July 1, 1990
Type II estrogen binding sites (EBS) in intracranial tumorsA Capelli, M Piantelli, A Rinelli, et al.
International Journal of Cancer|February 1, 2000
Quercetin inhibits p21-RAS expression in human colon cancer cell lines and in primary colorectal tumorsF O Ranelletti, N Maggiano, F G Serra, et al.
Gynecologic Oncology|April 1, 1992
Inhibitory effect of quercetin on primary ovarian and endometrial cancers and synergistic activity with cis-diamminedichloroplatinum (II)G Scambia, F O Ranelletti, P Benedetti Panici, et al.
Pageof 17